All In Biotech

Free tool

FAERS Monitor: Meropenem

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215212 or its brand name (Meropenem, Meropenem). Reports on generic versions are filed under their own applications.

Reports

32,715

Serious

31,766

97% of reports

Hospitalization

17,447

Death reported

9,722

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,620
  • off label use3,390
  • pyrexia2,230
  • pneumonia1,510
  • septic shock1,472
  • sepsis1,429
  • multiple organ dysfunction syndrome1,356
  • acute kidney injury1,317
  • condition aggravated1,295
  • thrombocytopenia1,153
  • febrile neutropenia1,149
  • respiratory failure1,143
  • diarrhoea1,139
  • drug interaction986
  • neutropenia960

Reports by year received

View as table
YearReports
2004101
200599
2006135
2007203
2008228
2009299
2010409
2011737
2012788
2013666
2014658
2015870
20161,203
20171,529
20182,137
20192,342
20202,810
20213,235
20222,870
20232,878
20243,227
20253,082
20262,206

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,444 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple organ dysfunction syndromeSignal1,35632.330.639,149
septic shockSignal1,47222.521.429,228
febrile neutropeniaSignal1,14911.310.710,641
respiratory failureSignal1,14310.29.69,382
sepsisSignal1,4298.37.99,141
thrombocytopeniaSignal1,1536.76.35,543
acute kidney injurySignal1,3175.65.34,930
neutropeniaSignal9604.64.32,667
pyrexiaSignal2,2304.24.05,412
drug interactionSignal9864.03.82,232
pneumoniaSignal1,5103.02.92,044
condition aggravatedSignal1,2952.72.61,451
off label useSignal3,3902.52.43,154
drug ineffectiveSignal4,6202.32.23,442
diarrhoea1,1391.11.119

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.